Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 27, 2010 10:30 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics to Showcase New DERMACYTE(R) Oxygen-Enriched Lotions at Leading Spa and Resort Conference in New York City

DURHAM, N.C., Sept. 27, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) will showcase for the first time its DERMACYTE oxygen-rich skin care products at...
September 23, 2010 02:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Receives DSMB Approval to Proceed to the Next Cohort in Its Phase II-B Clinical Trial for Traumatic Brain Injury

DURHAM, N.C., Sept. 23, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) reported today that the Data Safety Monitoring Board overseeing the company's...
September 20, 2010 02:00 ET | Source: Tenax Therapeutics, Inc.

U.S. Navy Broadens CRADA With Oxygen Biotherapeutics to Include Preclinical Studies Assessing Oxycyte(R) for Spinal Cord Injury Due to Decompression Sickness and for Hemorrhagic Shock

DURHAM, N.C., Sept. 20, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has amended an existing Cooperative Research and Development...
September 09, 2010 20:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Reports First Quarter FY2011 Financial Results

DURHAM, N.C., Sept. 9, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
September 09, 2010 18:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics to Host Shareholder Presentation and Present at the 10th Annual Biotech Forum in Zurich, Switzerland

DURHAM, N.C., Sept. 9, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that the Company will host a presentation to shareholders on...
September 07, 2010 20:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics TBI Study to be Offered to Injured Israeli Soldiers

DURHAM, N.C., Sept. 7, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
September 03, 2010 18:52 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Announces First Quarter FY2011 Financial Results Conference Call and Webcast

DURHAM, N.C., Sept. 3, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
September 01, 2010 09:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics to Present at Rodman & Renshaw Conference in New York

DURHAM, N.C., Sept. 1, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that the company will present at the Rodman & Renshaw Annual Global...
August 31, 2010 08:00 ET | Source: Tenax Therapeutics, Inc.

Study Shows DERMACYTE(R) Oxygen Concentrate Appears to Improve the Appearance of Fine Lines and the Perception of Skin Appearance

DURHAM, N.C., Aug. 31, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that results from an 8-week cosmetic study showed that the topical...
August 03, 2010 07:50 ET | Source: Tenax Therapeutics, Inc.

Photo Release -- DERMACYTE(R) Oxygen Concentrate Now Available in 10ml Pump Bottles

DURHAM, N.C., Aug. 3, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that the Company now offers its revolutionary anti-aging,...